MDMA, psychedelic mushroom studies to move to recruitment phase

Alex Crowe
By Alex Crowe
January 9 2021 - 5:30pm
A 3D rendering of 3,4-Methylenedioxymethamphetamine, or an MDMA molecule. Picture: Shutterstock

Several studies into psychedelics' potential to treat mental illness will begin recruiting participants for trials in 2021 as Australia's work in the field moves out of the shadows.

Advertisement

Ad

Advertisement

Ad
Alex Crowe

Alex Crowe

Science and Environment Reporter

Alex covers science and environment issues, with a focus on local Canberra stories. alex.crowe@austcommunitymedia.com.au

Get the latest Canberra news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.